(Q34759344)

4 August 2017

title

Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study (English)

1 reference

4 August 2017

Cyproterone acetate for severe hirsutism:results of a double-blind dose-ranging study (English)

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03489.X

5 December 2022

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832346

5 December 2022

physiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832346

5 December 2022

developed country

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832346

5 December 2022

Northern Europe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832346

5 December 2022

hormone antagonist

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832346

5 December 2022

Double-blind studies

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832346

5 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03489.X

5 December 2022

author name string

J. H. Barth

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832346

5 December 2022

C. A. Cherry

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832346

5 December 2022

F. Wojnarowska

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832346

5 December 2022

R. P. Dawber

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832346

5 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1832346

5 December 2022

publication date

1 July 1991

1 reference

full work available at URL

4 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2265.1991.tb03489.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03489.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.1991.tb03489.x/fullpdf

5 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03489.X

5 December 2022

published in

Clinical Endocrinology

1 reference

4 August 2017

volume

35

1 reference

4 August 2017

issue

1

1 reference

4 August 2017

page(s)

5-10

1 reference

Statistical methods for assessing agreement between two methods of clinical measurement

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1991.TB03489.X

Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1991.TB03489.X

Antiandrogens in the treatment of acne and hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1991.TB03489.X

Acne is not associated with abnormal plasma androgens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1991.TB03489.X

Treatment of hirsutism and acne with cyproterone acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1991.TB03489.X

Spironolactone is an effective and well tolerated systemic antiandrogen therapy for Hirsute women

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03489.X

Clinical efficacy and safety of cyproterone acetate in severe hirsutism: results of a multicentered Canadian study**Sponsored by the Canadian Fertility Research Association and funded by a grant-in-aid from Berlen Laboratories Limited, Canada.††T

5 December 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03489.X

IDIOPATHIC HIRSUTISM. SEASONAL VARIATION OF HAIR-GROWTH AND RESPONSE TO OESTROGEN ADMINISTRATION

5 December 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03489.X

Clinical assessment of body hair growth in women

5 December 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03489.X

5 December 2022

German medical monthly

9

14

599

Hammerstein J.

1969

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03489.X

Statistical ritual in clinical journals: is there a cure?--II

5 December 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03489.X

Anti-androgen treatment in women with acne: a controlled trial

5 December 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03489.X

5 December 2022

Identifiers

1 reference

4 August 2017

1 reference